search
Back to results

Ritanserin in Treatment of Cocaine Dependence - 1

Primary Purpose

Cocaine-Related Disorders

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Ritanserin
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Cocaine Dependence, ritanserin

Eligibility Criteria

28 Years - 47 Years (Adult)MaleDoes not accept healthy volunteers

Please contact site for information.

Sites / Locations

  • University of Pennsylvania

Outcomes

Primary Outcome Measures

Cocaine use
Cocaine craving

Secondary Outcome Measures

Full Information

First Posted
September 20, 1999
Last Updated
May 26, 2015
Sponsor
University of Pennsylvania
Collaborators
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00000187
Brief Title
Ritanserin in Treatment of Cocaine Dependence - 1
Official Title
Ritanserin in Treatment of Cocaine Dependence
Study Type
Interventional

2. Study Status

Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
July 1992 (undefined)
Primary Completion Date
June 1994 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
Collaborators
National Institute on Drug Abuse (NIDA)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
Cocaine Dependence, ritanserin

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Ritanserin
Primary Outcome Measure Information:
Title
Cocaine use
Title
Cocaine craving

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
28 Years
Maximum Age & Unit of Time
47 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Cornish, M.D.
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104 6178
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
11137283
Citation
Cornish JW, Maany I, Fudala PJ, Ehrman RN, Robbins SJ, O'Brien CP. A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug Alcohol Depend. 2001 Jan 1;61(2):183-9. doi: 10.1016/s0376-8716(00)00140-x.
Results Reference
background

Learn more about this trial

Ritanserin in Treatment of Cocaine Dependence - 1

We'll reach out to this number within 24 hrs